Restrepo-Vera, JL http://orcid.org/0000-0002-6332-6126
Coscojuela, P.
Fonseca, E. http://orcid.org/0000-0002-3895-1237
Quintana, M.
Sarria-Estrada, S.
Santamarina, E.
Abraira, L.
Sueiras, M.
Thonon, V.
Álvarez-Sabin, J.
Toledo, M.
Rovira, A.
Article History
Received: 17 November 2021
Revised: 29 January 2022
Accepted: 31 January 2022
First Online: 13 February 2022
Declarations
:
: EF declares speaker fees from UCB Pharma, Esteve laboratorios, Eisai Inc and Sanofi Genzyme. ES declares speaker fees from UCB Pharma, BIAL Pharmaceutical, EISAI Inc. Arvelle and Esteve laboratorios. LA declares speaker fees from UCB Pharma, BIAL Pharmaceutical, EISAI Inc., Sanofi Genzyme and Esteve laboratorios. MT has received speaker honoraria from UCB Pharma, Esteve, BIAL Laboratories, and Sanofi. The other authors declare no financial or other conflicts of interest.
: We confirm that we have read the Journal’s position on issues concerning ethical publication and affirm that this report is consistent with those guidelines.
Free to read: This content has been made available to all.